Richard F Pops Neurocrine Biosciences Inc (NBIX) insider trading activity

Richard F Pops is Director of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 34,480 shares of NBIX, which is worth approximately $4.42 Million. The most recent transaction as insider was on May 22, 2025, when has been sold 2,869 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.5K

9.08% 3M change

9.08% 12M change

Total Value Held $4.42 Million

RICHARD F POPS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 22 2025	BUY Exercise of conversion of derivative security	-	2,869 Added 7.68%	34,480 Common Stock
May 17 2024	SELL Open market or private sale	$297,864 $141.84 p/Share	2,100 Reduced 6.23%	31,611 Common Stock
May 17 2024	BUY Exercise of conversion of derivative security	-	4,199 Added 11.08%	33,711 Common Stock
Mar 13 2024	SELL Open market or private sale	$3,255,656 $140.33 p/Share	23,200 Reduced 44.01%	29,512 Common Stock
Mar 13 2024	BUY Exercise of conversion of derivative security	$992,032 $42.76 p/Share	23,200 Added 30.56%	52,712 Common Stock
Mar 11 2024	SELL Open market or private sale	$14,000 $140.0 p/Share	100 Reduced 0.34%	29,512 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	$4,276 $42.76 p/Share	100 Added 0.34%	29,612 Common Stock
Mar 08 2024	SELL Open market or private sale	$238,085 $140.05 p/Share	1,700 Reduced 5.45%	29,512 Common Stock
Mar 08 2024	BUY Exercise of conversion of derivative security	$72,692 $42.76 p/Share	1,700 Added 5.17%	31,212 Common Stock
Feb 20 2024	SELL Open market or private sale	$1,987,050 $132.47 p/Share	15,000 Reduced 33.7%	29,512 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	$194,700 $12.98 p/Share	15,000 Added 25.21%	44,512 Common Stock
Jan 03 2023	SELL Open market or private sale	$1,788,000 $119.2 p/Share	15,000 Reduced 33.7%	29,512 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	$190,650 $12.71 p/Share	15,000 Added 25.21%	44,512 Common Stock
May 09 2022	SELL Open market or private sale	$1,144,500 $76.3 p/Share	15,000 Reduced 33.7%	29,512 Common Stock
May 09 2022	BUY Exercise of conversion of derivative security	$99,900 $6.66 p/Share	15,000 Added 28.84%	37,012 Common Stock

Also insider at

ALKS

Alkermes plc. Healthcare

Director and CEO, Alkermes plc

RFP

Richard F Pops

Director

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Value

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX

Account